U.S. health officials deploy medical AI agents despite safety concerns
Federal projects roll out AI systems that offer therapy and prescribe medicine, raising questions about oversight and venture capital influence.
What to know
- Federal health officials are deploying AI systems capable of providing therapy and prescribing medication.
- Safety and regulatory oversight are the primary concerns raised about these deployments.
- Venture capital influence on medical AI development is flagged as a potential conflict of interest.
“Federal projects are rolling out A.I. agents that offer therapy and prescribe medicine, raising concerns about safety and the influence of venture capital investors.”
Christina Jewett, NYT reporter · New York Times ↗ · Sep 14, 9:58 AM
U.S. Health Officials Government agencies deploying AI systemsChristina Jewett Reporter
How it unfolded 1 development · click the chart to see its coverage articlesposts
-
1
NYT reports federal rollout of AI agents for therapy and prescriptions
The New York Times reports that U.S. health officials are moving quickly to deploy AI agents that offer therapy and prescribe medicine through federal projects, raising concerns about safety and venture capital influence.
-
first by Mastodon, 9d ago · also NYT, Philadelphia Inquirer, NYT Health, NYT Science
2 more headlines
- Trump Administration Moves to Integrate A.I. Into Medical Care Despite Concerns NYT · 9d ago
- U.S. health officials move quickly to deploy medical AI despite concerns Philadelphia Inquirer · 8d ago
-
B
US Health Officials Move Quickly to Deploy Medical AI Despite Concerns. Federal projects are rolling out AI agents that offer therapy and prescribe medicine, raising concerns about safety and the influence of venture capital investors. https://www. nytimes.com/2026/09/14/health/ ai-doctors-medicare-fda.html?smid=bs-share
-